DNAnexus has raised $15 million in Series C funding from Google, Claremont, TPG, and First Round Capital
DNAnexus is a startup that has raised $15 million in Series C funding led by Google Ventures. Other investors that participated in this round include Claremont Creek Ventures, First Round Capital and TPG Biotech. Nat Goldhaber of Claremont will join the board of directors at DNAnexus. DNAnexus offers online tools for analyzing DNA data.
“This is an exciting time of growth for DNAnexus. This funding will significantly expand our capacity to support the growing number of commercial and academic labs around the world utilizing our platform to manage DNA data and analyses in a clinically appropriate manner. We welcome Claremont Creek Ventures to the team and are pleased with the continued support from Google Ventures, TPG Biotech, and First Round Capital,” stated Richard Daly, CEO of DNAnexus.
DNAnexus accelerates basic science and clinical breakthroughs by offering a centralized hub for managing data and collaborating with other scientists. DNAnexus also offers sharing tools and accessing diverse reference datasets, including genotypic and phenotypic data.
“The next wave of insights in genetics comes from multi-institutional collaborative efforts producing huge amounts of data. DNAnexus has created a system where large enterprises, laboratories, and individuals can collaborate more efficiently using modern cloud technologies,” stated Krishna Yeshwant, Google Ventures General Partner and DNAnexus board member. “DNAnexus is changing how global biomedical research and development markets manage DNA data and analytic infrastructures.”